Form DEFA14A - Additional definitive proxy soliciting materials and Rule 14(a)(12) material:
SEC Accession No. 0000950170-25-060316
Filing Date
2025-04-29
Accepted
2025-04-29 17:05:04
Documents
3

Document Format Files

Seq Description Document Type Size
1 DEFA14A eldn-2025-proxy-defa_14a.htm DEFA14A 27455
2 GRAPHIC img54275914_0.jpg GRAPHIC 545560
3 GRAPHIC img54275914_1.jpg GRAPHIC 267879
  Complete submission text file 0000950170-25-060316.txt   1148428
Mailing Address 19800 MACARTHUR BLVD. SUITE 250 IRVINE CA 92612
Business Address 19800 MACARTHUR BLVD. SUITE 250 IRVINE CA 92612 949-238-8090
Eledon Pharmaceuticals, Inc. (Filer) CIK: 0001404281 (see all company filings)

EIN.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: DEFA14A | Act: 34 | File No.: 001-36620 | Film No.: 25889066
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)